Overview

SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The study aimed to pilot the viability of a full scale randomised comparison of 2 steroid doses in malignant spinal cord compression, to establish safety of high dose dexamethasone in this setting in Australia, to test web registration and randomisation and to compare different functional outcome measures.
Phase:
Phase 2
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group
Trans-Tasman Radiation Oncology Group (TROG)
Collaborator:
Cancer Council New South Wales
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate